Abstract

BackgroundGlycated hemoglobin (HbA1c) and glycated albumin (GA) are frequently used as glycemic control markers. However, these markers are influenced by alterations in hemoglobin and albumin metabolism. Thus, conditions such as anemia, chronic renal failure, hypersplenism, chronic liver diseases, hyperthyroidism, hypoalbuminemia, and pregnancy need to be considered when interpreting HbA1c or GA values. Using data from patients with normal albumin and hemoglobin metabolism, we previously established a linear regression equation describing the GA value versus the HbA1c value to calculate an extrapolated HbA1c (eHbA1c) value for the accurate evaluation of glycemic control. In this study, we investigated the difference between the measured HbA1c and the eHbA1c values for patients with various conditions.MethodsData sets for a total of 2461 occasions were obtained from 731 patients whose HbA1c and GA values were simultaneously measured. We excluded patients with missing data or changeable HbA1c levels, and patients who had received transfusions or steroids within the previous 3 months. Finally, we included 44 patients with chronic renal failure (CRF), 10 patients who were undergoing hemodialysis (HD), 7 patients with hematological malignancies and a hemoglobin level of less than 10 g/dL (HM), and 12 patients with chronic liver diseases (CLD).ResultsIn all the groups, the eHbA1c values were significantly higher than the measured HbA1c values. The median difference was 0.75 % (95 % CI 0.40–1.10 %, P for the difference is <0.001) in the CRF group, 0.80 % (95 % CI 0.30–1.65 %, P for the difference is 0.041) in the HD group, 0.90 % (95 % CI 0.90–1.30 %, P for the difference is 0.028) in the HM group, and 0.85 % (95 % CI 0.40–1.50 %, P for the difference is 0.009) in the CLD group.ConclusionsWe found that the measured HbA1c values were lower than the eHbA1c values in each of the groups.

Highlights

  • Glycated hemoglobin (HbA1c) and glycated albumin (GA) are frequently used as glycemic control markers

  • These glycemic control markers are well correlated with blood glucose levels, HbA1c is influenced by alterations in hemoglobin metabolism and GA is influenced by alterations in albumin metabolism

  • We calculated the extrapolated HbA1c (eHbA1c) value using an equation for each of the several groups of patients suffering from various diseases, and investigated the difference from the measured HbA1c values

Read more

Summary

Introduction

Glycated hemoglobin (HbA1c) and glycated albumin (GA) are frequently used as glycemic control markers. GA is used as an index of short-term glycemic control [2] These glycemic control markers are well correlated with blood glucose levels, HbA1c is influenced by alterations in hemoglobin metabolism and GA is influenced by alterations in albumin metabolism. Clin Exp Nephrol (2015) 19:1179–1183 conditions such as anemia, chronic renal failure, hypersplenism, chronic liver diseases, hyperthyroidism, hypoalbuminemia, and pregnancy need to be considered when interpreting HbA1c or GA values. These markers are influenced by alterations in hemoglobin and albumin metabolism. Conditions such as anemia, chronic renal failure, hypersplenism, chronic liver diseases, hyperthyroidism, hypoalbuminemia, and pregnancy need to be considered when interpreting HbA1c or GA values. We investigated the difference between the measured HbA1c and the eHbA1c values for patients with various conditions

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call